Table 3.

Postoperative data for patients submitted to isolated Roux loop pancreaticojejunostomy (IRPJ) or pancreaticogastrostomy (PG)

Variable	All patients	IRPJ group	PG group	P-value
	(n = 90)	(n = 45)	(n = 45)
Hospital stay, days, median (range)	8 (4–41)	8 (5–41)	9 (4–34)	0.448
Time to drain removal, days, median (range)	8 (4–35)	7.5 (5–35)	9 (4–34)	0.118
Amount of draining, ml, median (range)	900 (65–17000)	850 (70–15000)	950 (65–17000)	0.705
Time to oral feeding, days, median (range)	6 (4–30)	5 (4–20)	6 (4–30)	0.029
Patients with complications, n (%)	31 (34.4%)	14	17	0.506
Complication grade, n (%)
I	3 (3.3%)	2	1	0.724
II	10 (11.1%)	5	5
IIIa	5 (5.6%)	2	3
IIIb	6 (6.7%)	2	4
IV	7 (7.8%)	3	4
V	7 (7.8%)	3	4
Severity of complications, n (%)
Minor (<IIIb)	14 (15.5%)	8	6	0.385
Major (>IIIb)	17 (18.9%)	6	11
Pancreatic leakage (POPF), n (%)	19 (21.1%)	9	10	0.796
POPF Grade A, n (%)	8 (8.9%)	5	3	0.710
POPF Grade B, n (%)	5 (5.6%)	2	3
POPF Grade C, n (%)	6 (6.7%)	2	4
Pancreatitis, n (%)	3 (3.3%)	2	1	0.557
Biliary leakage, n (%)	10 (11.1%)	4	6	0.502
Delayed gastric emptying, n (%)	13 (14.4%)	4	9	0.134
Obstructed GJ, n (%)	2 (2.2%)	1	1	1
Bleeding GJ, n (%)	2 (2.2%)	1	1	1
Bleeding PG, n (%)	2 (2.2%)	0	2	0.153
Internal haemorrhage, n (%)	2 (2.2%)	1	1	1
Wound infection, n (%)	5 (5.6%)	3	2	0.645
Liver failure, n (%)	1 (1.1%)	1	0
Pulmonary complications, n (%)	4 (4.4%)	2	2	1
Re-exploration, n (%)	7 (7.8%)	3	4	0.694
Readmission rate at 3 months, n (%)	6 (6.7%)	2	4	0.398
Mortality, n (%)	7 (7.8%)	3	4	0.694
Pulmonary embolism, n (%)	1 (1.1%)	1	0
SIRS secondary to POPF, n (%)	5 (5.6%)	2	3
Liver failure, n (%)	1 (1.1%)	0	1

POPF, postoperative pancreatic fistula; GJ, gastrojejunostomy; PG, pancreaticogastrostomy; SIRS, systemic inflammatory response syndrome.